The Local Lymph Node Assay represents a non-radioactive adaptation of the LLNA approach for identifying potential skin sensitizing test substances and assessing the proliferation of lymphocytes induced in the auricular lymph nodes. This method, conducted in mice, relies on measuring the content of 5-bromo-2-deoxyuridine (BrdU), an analogue of thymidine, as an indicator of such proliferation.